These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8596790)

  • 1. Prevention of microvascular thrombosis by topical application of recombinant tissue factor pathway inhibitor.
    Lantieri LA; Ozbek MR; Deune EG; Ornberg RL; Brown DM; Chung SH; Wun TC; Cooley BC; Khouri RK
    Plast Reconstr Surg; 1996 Mar; 97(3):587-94. PubMed ID: 8596790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model.
    Fu K; Izquierdo R; Walenga JM; Fareed J
    Thromb Res; 1995 Jun; 78(5):421-8. PubMed ID: 7660358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tissue factor pathway inhibitor improves free-flap survival in a model simulating free-flap errors.
    Ozbeck MR; Brown DM; Deune EG; Lantieri LA; Kania NM; Pasia EN; Cooley BC; Wun TC; Khouri RK
    J Reconstr Microsurg; 1995 May; 11(3):185-8. PubMed ID: 7650643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma.
    Khouri RK; Koudsi B; Kaiding F; Ornberg RL; Wun TC
    Ann Plast Surg; 1993 May; 30(5):398-402; discussion 402-4. PubMed ID: 8342923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antithrombotic effect of the new recombinant hirudin HBW 023 and heparin in small arteries and veins.
    Zhang B; Wieslander JB
    Microsurgery; 1996; 17(2):89-96. PubMed ID: 8914063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass model.
    Rapp JH; Pan XM; Ghermay A; Gazetas P; Brady SE; Reilly LM
    J Vasc Surg; 1997 Apr; 25(4):726-9. PubMed ID: 9129630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor.
    Arnljots B; Bergqvist D
    Plast Reconstr Surg; 1995 Apr; 95(5):894-900. PubMed ID: 7708874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of tissue factor pathway inhibitor (TFPI) as topically applied antithrombotic agent.
    Aagaard S; Hjortdal VE; Barker JH
    APMIS Suppl; 2003; (109):102-7. PubMed ID: 12874959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topically applied tissue factor pathway inhibitor reduced intimal thickness of small arterial autografts in rabbits.
    Sun LB; Utoh J; Moriyama S; Tagami H; Okamoto K; Kitamura N
    J Vasc Surg; 2001 Jul; 34(1):151-5. PubMed ID: 11436089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa.
    Arnljots B; Ezban M; Hedner U
    J Vasc Surg; 1997 Feb; 25(2):341-6. PubMed ID: 9052569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hirudin causes more bleeding than heparin in a rabbit ear bleeding model.
    Klement P; Liao P; Hirsh J; Johnston M; Weitz JI
    J Lab Clin Med; 1998 Sep; 132(3):181-5. PubMed ID: 9735923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical heparin enhances patency in a rat model of arterial thrombosis.
    Braam MJ; Cooley BC; Gould JS
    Ann Plast Surg; 1995 Feb; 34(2):148-51; discussion 151-3. PubMed ID: 7741432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis.
    Marsh Lyle E; Lewis SD; Lehman ED; Gardell SJ; Motzel SL; Lynch JJ
    Thromb Haemost; 1998 Mar; 79(3):656-62. PubMed ID: 9531058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
    Ohyama T; Hori T; Moriike M; Asano T; Hayashi H; Iwade K; Hosoda S
    Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of recombinant tissue-type plasminogen activator thrombolysis with a selective factor Xa inhibitor derived from the leech Hirudo medicinalis: comparison with heparin and hirudin in a rabbit thrombosis model.
    Kornowski R; Eldor A; Werber MM; Ezov N; Zwang E; Nimrod A; Chernine A; Finkelstein A; Panet A; Laniado S; Keren G
    Coron Artery Dis; 1996 Dec; 7(12):903-9. PubMed ID: 9116933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
    van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
    J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model.
    Fu K; Izquierdo R; Vandevender D; Warpeha RL; Wolf H; Fareed J
    Thromb Res; 1997 Jun; 86(5):355-61. PubMed ID: 9211626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.